United States Influenza Vaccine Market Report & Forecast 2021-2027
Table of Contents1 Introduction to Research & Analysis Reports
1.1 Influenza Vaccine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 United States Influenza Vaccine Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 United States Influenza Vaccine Overall Market Size
2.1 United States Influenza Vaccine Market Size: 2021 VS 2027
2.2 United States Influenza Vaccine Revenue, Prospects & Forecasts: 2016-2027
2.3 United States Influenza Vaccine Sales: 2016-2027
3 Company Landscape
3.1 Top Influenza Vaccine Players in United States Market
3.2 Top United States Influenza Vaccine Companies Ranked by Revenue
3.3 United States Influenza Vaccine Revenue by Companies
3.4 United States Influenza Vaccine Sales by Companies
3.5 United States Influenza Vaccine Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Influenza Vaccine Companies in United States Market, by Revenue in 2020
3.7 Manufacturers Influenza Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Influenza Vaccine Players in United States Market
3.8.1 List of Tier 1 Influenza Vaccine Companies in United States
3.8.2 List of Tier 2 and Tier 3 Influenza Vaccine Companies in United States
4 Sights by Type
4.1 Overview
4.1.1 By Type - United States Influenza Vaccine Market Size Markets, 2021 & 2027
4.1.2 Trivalent Influenza Vaccine
4.1.3 Quadrivalent Influenza Vaccine
4.2 By Type - United States Influenza Vaccine Revenue & Forecasts
4.2.1 By Type - United States Influenza Vaccine Revenue, 2016-2021
4.2.2 By Type - United States Influenza Vaccine Revenue, 2022-2027
4.2.3 By Type - United States Influenza Vaccine Revenue Market Share, 2016-2027
4.3 By Type - United States Influenza Vaccine Sales & Forecasts
4.3.1 By Type - United States Influenza Vaccine Sales, 2016-2021
4.3.2 By Type - United States Influenza Vaccine Sales, 2022-2027
4.3.3 By Type - United States Influenza Vaccine Sales Market Share, 2016-2027
4.4 By Type - United States Influenza Vaccine Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - United States Influenza Vaccine Market Size, 2021 & 2027
5.1.2 For Children (6 months to 3 years)
5.1.3 For Adults and Children over 3 years
5.2 By Application - United States Influenza Vaccine Revenue & Forecasts
5.2.1 By Application - United States Influenza Vaccine Revenue, 2016-2021
5.2.2 By Application - United States Influenza Vaccine Revenue, 2022-2027
5.2.3 By Application - United States Influenza Vaccine Revenue Market Share, 2016-2027
5.3 By Application - United States Influenza Vaccine Sales & Forecasts
5.3.1 By Application - United States Influenza Vaccine Sales, 2016-2021
5.3.2 By Application - United States Influenza Vaccine Sales, 2022-2027
5.3.3 By Application - United States Influenza Vaccine Sales Market Share, 2016-2027
5.4 By Application - United States Influenza Vaccine Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 CSL
6.1.1 CSL Corporation Information
6.1.2 CSL Overview
6.1.3 CSL Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.1.4 CSL Influenza Vaccine Product Description
6.1.5 CSL Recent Developments
6.2 GSK
6.2.1 GSK Corporation Information
6.2.2 GSK Overview
6.2.3 GSK Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.2.4 GSK Influenza Vaccine Product Description
6.2.5 GSK Recent Developments
6.3 Sanofi Pasteur
6.3.1 Sanofi Pasteur Corporation Information
6.3.2 Sanofi Pasteur Overview
6.3.3 Sanofi Pasteur Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.3.4 Sanofi Pasteur Influenza Vaccine Product Description
6.3.5 Sanofi Pasteur Recent Developments
6.4 Mylan
6.4.1 Mylan Corporation Information
6.4.2 Mylan Overview
6.4.3 Mylan Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.4.4 Mylan Influenza Vaccine Product Description
6.4.5 Mylan Recent Developments
6.5 Hulan Bio
6.5.1 Hulan Bio Corporation Information
6.5.2 Hulan Bio Overview
6.5.3 Hulan Bio Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.5.4 Hulan Bio Influenza Vaccine Product Description
6.5.5 Hulan Bio Recent Developments
6.6 AstraZeneca
6.6.1 AstraZeneca Corporation Information
6.6.2 AstraZeneca Overview
6.6.3 AstraZeneca Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.6.4 AstraZeneca Influenza Vaccine Product Description
6.6.5 AstraZeneca Recent Developments
6.7 CCBIO
6.7.1 CCBIO Corporation Information
6.7.2 CCBIO Overview
6.7.3 CCBIO Influenza Vaccine Sales and Revenue in United States Market (2016-2021)
6.7.4 CCBIO Influenza Vaccine Product Description
6.7.5 CCBIO Recent Developments
7 United States Influenza Vaccine Production Capacity, Analysis
7.1 United States Influenza Vaccine Production Capacity, 2016-2027
7.2 Influenza Vaccine Production Capacity of Key Manufacturers in United States Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Influenza Vaccine Supply Chain Analysis
9.1 Influenza Vaccine Industry Value Chain
9.2 Influenza Vaccine Upstream Market
9.3 Influenza Vaccine Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Influenza Vaccine Distributors and Sales Agents in United States Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of TablesTable 1. Key Players of Influenza Vaccine in United States Market
Table 2. Top Influenza Vaccine Players in United States Market, Ranking by Revenue (2019)
Table 3. United States Influenza Vaccine Revenue by Companies, (US$, Mn), 2016-2021
Table 4. United States Influenza Vaccine Revenue Share by Companies, 2016-2021
Table 5. United States Influenza Vaccine Sales by Companies, (M Doses), 2016-2021
Table 6. United States Influenza Vaccine Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Influenza Vaccine Price (2016-2021) & (USD/Doses)
Table 8. Manufacturers Influenza Vaccine Product Type
Table 9. List of Tier 1 Influenza Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Influenza Vaccine Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Trivalent Influenza Vaccine
Table 12. Major Manufacturers of Quadrivalent Influenza Vaccine
Table 13. By Type - United States Influenza Vaccine Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - United States Influenza Vaccine Revenue (US$, Mn), 2016-2021
Table 15. By Type - United States Influenza Vaccine Revenue (US$, Mn), 2022-2027
Table 16. By Type - United States Influenza Vaccine Sales (M Doses), 2016-2021
Table 17. By Type - United States Influenza Vaccine Sales (M Doses), 2022-2027
Table 18. By Application - United States Influenza Vaccine Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - United States Influenza Vaccine Revenue (US$, Mn), 2016-2021
Table 20. By Application - United States Influenza Vaccine Revenue (US$, Mn), 2022-2027
Table 21. By Application - United States Influenza Vaccine Sales (M Doses), 2016-2021
Table 22. By Application - United States Influenza Vaccine Sales (M Doses), 2022-2027
Table 23. CSL Corporation Information
Table 24. CSL Description and Major Businesses
Table 25. CSL Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 26. CSL Influenza Vaccine Product
Table 27. CSL Recent Developments
Table 28. GSK Corporation Information
Table 29. GSK Description and Major Businesses
Table 30. GSK Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 31. GSK Influenza Vaccine Product
Table 32. GSK Recent Developments
Table 33. Sanofi Pasteur Corporation Information
Table 34. Sanofi Pasteur Description and Major Businesses
Table 35. Sanofi Pasteur Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 36. Sanofi Pasteur Influenza Vaccine Product
Table 37. Sanofi Pasteur Recent Developments
Table 38. Mylan Corporation Information
Table 39. Mylan Description and Major Businesses
Table 40. Mylan Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 41. Mylan Influenza Vaccine Product
Table 42. Mylan Recent Developments
Table 43. Hulan Bio Corporation Information
Table 44. Hulan Bio Description and Major Businesses
Table 45. Hulan Bio Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 46. Hulan Bio Influenza Vaccine Product
Table 47. Hulan Bio Recent Developments
Table 48. AstraZeneca Corporation Information
Table 49. AstraZeneca Description and Major Businesses
Table 50. AstraZeneca Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 51. AstraZeneca Influenza Vaccine Product
Table 52. AstraZeneca Recent Developments
Table 53. CCBIO Corporation Information
Table 54. CCBIO Description and Major Businesses
Table 55. CCBIO Influenza Vaccine Sales (M Doses), Revenue (US$, Mn) and Gross Margin (USD/Doses) (2016-2021)
Table 56. CCBIO Influenza Vaccine Product
Table 57. CCBIO Recent Developments
Table 58. Influenza Vaccine Production Capacity (M Doses) of Key Manufacturers in United States Market, 2019-2021 (M Doses)
Table 59. United States Influenza Vaccine Capacity Market Share of Key Manufacturers, 2019-2021
Table 60. Influenza Vaccine Market Opportunities & Trends in United States Market
Table 61. Influenza Vaccine Market Drivers in United States Market
Table 62. Influenza Vaccine Market Restraints in United States Market
Table 63. Influenza Vaccine Raw Materials
Table 64. Influenza Vaccine Raw Materials Suppliers in United States Market
Table 65. Typical Influenza Vaccine Downstream
Table 66. Influenza Vaccine Downstream Clients in United States Market
Table 67. Influenza Vaccine Distributors and Sales Agents in United States Market
List of FiguresFigure 1. Influenza Vaccine Product Picture
Figure 2. Influenza Vaccine Segment by Type
Figure 3. Influenza Vaccine Segment by Application
Figure 4. United States Influenza Vaccine Market Overview: 2020
Figure 5. United States Influenza Vaccine Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. United States Influenza Vaccine Revenue, 2016-2027 (US$, Mn)
Figure 7. Influenza Vaccine Sales in United States Market: 2016-2027 (M Doses)
Figure 8. The Top 3 and 5 Players Market Share by Influenza Vaccine Revenue in 2020
Figure 9. Trivalent Influenza Vaccine Product Picture
Figure 10. Quadrivalent Influenza Vaccine Product Picture
Figure 11. By Type - United States Influenza Vaccine Sales Market Share, 2016-2027
Figure 12. By Type - United States Influenza Vaccine Revenue Market Share, 2016-2027
Figure 13. By Type - United States Influenza Vaccine Price (USD/Doses), 2016-2027
Figure 14. For Children (6 months to 3 years)
Figure 15. For Adults and Children over 3 years
Figure 16. By Application - United States Influenza Vaccine Sales Market Share, 2016-2027
Figure 17. By Application - United States Influenza Vaccine Revenue Market Share, 2016-2027
Figure 18. By Application - United States Influenza Vaccine Price (USD/Doses), 2016-2027
Figure 19. CSL Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 20. GSK Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 21. Sanofi Pasteur Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. Mylan Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Hulan Bio Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. AstraZeneca Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. CCBIO Influenza Vaccine Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. United States Influenza Vaccine Production Capacity (M Doses), 2016-2027
Figure 27. Influenza Vaccine Industry Value Chain
Figure 28. Marketing Channels